Biomerica (BMRA) Non-Current Assets (2011 - 2026)
Biomerica (BMRA) reported Non-Current Assets of $755000.0 for Q1 2026, down 35.58% on a YoY basis from $1.2 million in Q1 2025, and down 10.44% sequentially from $843000.0 in Q4 2025.
Biomerica (BMRA) Non-Current Assets (2011 - 2026) Analysis & Trends
Biomerica (BMRA) has 16 years of Non-Current Assets data on file, last reported at $755000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 35.58% year-over-year to $755000.0; the trailing twelve-month figure through Feb 2026 stood at $3.6 million (down 33.51% YoY), and the FY2025 full-year result was $1.1 million, down 29.74% from the prior year.
- Non-Current Assets declined to $755000.0 in Q1 2026, from $843000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $2.3 million in Q1 2022 to a low of $755000.0 in Q1 2026.
- A 5-year average of $1.5 million and a median of $1.5 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets fell 8.09% in 2024 and tumbled 36.57% in 2025, its largest moves.
- Tracing BMRA's Non-Current Assets over 5 years: stood at $1.8 million in 2022, then fell by 13.43% to $1.6 million in 2023, then slipped by 15.13% to $1.3 million in 2024, then plunged by 36.57% to $843000.0 in 2025, then retreated by 10.44% to $755000.0 in 2026.
- Business Quant data shows BMRA's Non-Current Assets at $755000.0 in Q1 2026, $843000.0 in Q4 2025, and $955000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 755,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 755,000.00 |
| Nov 30, 2025 | 843,000.00 |
| Aug 31, 2025 | 955,000.00 |
| May 31, 2025 | 1.07 Mn |
| Feb 28, 2025 | 1.17 Mn |
| Nov 30, 2024 | 1.33 Mn |
| Aug 31, 2024 | 1.43 Mn |
| May 31, 2024 | 1.52 Mn |
| Feb 29, 2024 | 1.50 Mn |
| Nov 30, 2023 | 1.57 Mn |
| Aug 31, 2023 | 1.65 Mn |
| May 31, 2023 | 1.66 Mn |
| Feb 28, 2023 | 1.73 Mn |
| Nov 30, 2022 | 1.81 Mn |
| Aug 31, 2022 | 1.88 Mn |
| May 31, 2022 | 1.95 Mn |
| Feb 28, 2022 | 2.33 Mn |
| Nov 30, 2021 | 2.41 Mn |
| Aug 31, 2021 | 2.57 Mn |
| May 31, 2021 | 2.59 Mn |